Columbia University

Technology Ventures

2018 Irving Institute Translational Therapeutics Symposium

November 07, 2018
Columbia University Medical Center: Bard Hall
50 Haven Ave
New York NY

Overview: Presented by the Columbia Translational Therapeutics Accelerator, this full-day event will feature presentations and panel discussions from academic and industry leaders on the successful development and commercialization of academic innovations using precision therapeutics across various sectors. Details and a list of speakers is included below for your reference.


  • James Wilson, Professor of Medicine and Pediatrics; Director, Gene Therapy Program at University of Pennsylvania
  • Chas Bountra, Professor of Translational Medicine; Chief Scientist, Structural Genomics Consortium at Oxford University
  • Mark Kester, Professor of Pharmacology; Director, The Nanostar Institute at University of Virginia
  • Wafik El-Deiry, Professor of Oncology; Deputy Cancer Center Director at Fox Chase Cancer Center
  • Olivier Harari, Vice President of Therapeutic Areas, Early Clinical Development at Regeneron Pharmaceuticals
  • Julia Glade Bender, Vice Chair for Clinical Research, Department of Pediatrics at Memorial Sloan Kettering Cancer Center
  • Patrick Mayes, Executive Director, Head I-O Antibody Research at Incyte
  • Michael Spector, President and Chief Executive Officer, Caelum Biosciences
  • Konstantin Petrukhin, Associate Professor of Ophthalmology at Columbia University Medical Center
  • Angela Christiano, Professor of Dermatology, Genetics & Development; Associate Director of Epicure: Skin Disease Resource Based Center at Columbia University Medical Center
  • Michio Hirano, Professor of Neurology; Chief, Division of Neuromuscular Disorders at Columbia University Medical Center

In Partnership With: Irving Institute for Clinical and Translational Research, New York Presbyterian, Columbia University Irving Medical Center, Clinical & Translational Science Awards Program, Columbia Technology Ventures, Accelerating Cancer Therapeutics (ACT), Columbia Lab-to-Market Accelerator Network, Columbia Business School, Columbia Clinical Trials Office, Columbia Biomedical Technology Accelerator (BiomedX)